Bristol-Myers Squibb (BMY)
52.04
+0.28 +0.54%
NYSE
Apr 26, 20:00
Delayed 2m
USD
View All Key Stats
BMY Key Stats
| Income Statement | |
| Revenue (TTM) | 20.78B |
| Revenue (Quarterly YoY Growth) | Upgrade |
| EPS Diluted (TTM) | 0.60 |
| EPS Diluted (Quarterly YoY Growth) | Upgrade |
| Net Income (TTM) | 1.007B |
| Profitability | |
| Gross Profit Margin (Quarterly) | 69.30% |
| Profit Margin (Quarterly) | -42.72% |
| Dividend | |
| Dividend Yield (Forward) | Upgrade |
| Dividend Yield (TTM) | Upgrade |
| Price and Valuation | |
| Market Cap | 85.51B |
| 52 Week High (Daily) | Upgrade |
| 52 Week Low (Daily) | Upgrade |
| PS Ratio (TTM) | 4.159 |
| PE Ratio (TTM) | 87.17 |
| Price to Book Value | 7.283 |
| Other | |
| Beta (5Y) | Upgrade |
| Debt to Equity Ratio (Quarterly) | Upgrade |
| Free Cash Flow (Quarterly) | 863.00M |
| Return on Equity (TTM) | Upgrade |
View All BMY News
BMY News
-
WireHeadlineTime (ET)
-
MT Newswires04/26 15:58
-
MT Newswires04/26 08:51
-
MT Newswires04/26 08:22
-
SA Breaking News04/26 07:33
-
MT Newswires04/26 07:20
-
Business Wire04/26 06:59
-
MT Newswires04/26 06:56
-
SA Breaking News04/25 17:30
-
MT Newswires04/25 16:52
-
Business Wire04/25 16:20
View All Events
BMY Events
| Date | Type | Description |
|---|---|---|
| 04/27/2018 | Misc | Bristol-Myers Squibb Co First Quarter Earnings Conference Call in 2018 |
| 04/27/2018 | Earnings | Bristol-Myers Squibb Co First Quarter Earnings Results in 2018 |
| 04/05/2018 | Dividends | Amount: 0.40, Declared Date: Mar 01 2018, Pay Date: May 01 2018 |
| 02/13/2018 | Misc | Bristol-Myers Squibb Co Annual Report in 2017 |
| 02/05/2018 08:00 EST | Misc | Bristol-Myers Squibb Co Fourth Quarter Earnings Conference Call in 2017 |
| 02/05/2018 | Earnings | Bristol-Myers Squibb Co Fourth Quarter Earnings in 2017 Release |
| 01/04/2018 | Dividends | Amount: 0.40, Declared Date: Dec 07 2017, Pay Date: Feb 01 2018 |
| 10/26/2017 10:30 EDT | Misc | Bristol-Myers Squibb Co Third Quarter Earnings Conference Call in 2017 |
| 10/26/2017 | Earnings | Bristol-Myers Squibb Co Third Quarter Earnings in 2017 Release |
| 10/05/2017 | Dividends | Amount: 0.39, Declared Date: Sep 14 2017, Pay Date: Nov 01 2017 |
BMY Fundamentals
Income Statement View Statement
BMY Ratings
- Y-Rating Upgrade
- Value Score Upgrade
- Fundamental Score Upgrade
- Valuation (Hist. Mult.) Upgrade
- Y-Rating Report Download
Advertisement
BMY One Page Reports
- One Page Report Download
BMY Analyst Coverage
| Consensus Recommendations | |
| Buy Recommendations | Upgrade |
| Outperform Recommendations | Upgrade |
| Hold Recommendations | Upgrade |
| Underperform Recommendations | Upgrade |
| Sell Recommendations | Upgrade |
| Consensus Recommendation | Upgrade |
| Consensus Rating | Upgrade |
| Target Price | |
| Price | 52.04 |
| Price Target | Upgrade |
| Price Target Upside (Daily) | Upgrade |
Edit
Profile
- URL: http://www.bms.com
- Investor Relations URL: N/A
- HQ State/Province: New York
- Sector: Healthcare
- Industry: Drug Manufacturers - Major
- Equity Style: Large Cap/Blend
- Next Earnings Release: Apr. 27, 2018
- Last Earnings Release: Feb. 05, 2018
- Next Ex-Dividend Date: N/A
- Last Ex-Dividend Date: Apr. 05, 2018
- Description: Bristol-Myers Squibb Co is engaged in discovery, development, licensing, manufacturing, marketing, distribution and sale of biopharmaceuticals products. The company operates in one segment that is Biopharmaceuticals.
BMY Excel Add-In Codes
- Name: =YCI("BMY","name")
- Description: =YCI("BMY","description")
- Sector: =YCI("BMY","sector")
- Industry: =YCI("BMY","industry")
- Est. Current Fiscal Year End: =YCI("BMY","fye")
To find the codes for any of our financial metrics, see our Complete Reference of Metric Codes.
Access our powerful Excel Add-in with a YCharts Professional Membership. Learn More.
Other BMY Resources
- 13F Filings Whale Wisdom
- Call Transcripts Seeking Alpha
- Insider Trading Morningstar
- Institutional Ownership Nasdaq
- SEC Filings SEC
- BMY Tweets Stocktwits
Advertisement
